Biotech Archives - Page 105 of 795

2 minute read

Standard BioTools And Navignostics Announce Collaboration Agreement To Advance Imaging Capabilities In Personalized Medicine

February 7, 9:39 AM

Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced a collaboration agreement with Navignostics AG for development of

LAB

2 minute read

PetVivo Holdings Announces Release Of Clinical Study Results Involving Feline Tolerance To Intra-Articular Injections Of Spryng With OsteoCushion Technolgoy

By Benzinga Newsdesk

February 7, 9:25 AM

PetVivo Holdings, Inc. (NASDAQ:PETV, PETVW)))) (the "Company" or "PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals

PETV

1 minute read

Rhythm Pharmaceuticals Announces Approval Reimbursement Decision In Italy For IMCIVREE For The Treatment Of Obesity And Control Of Hunger In Bardet-Biedl Syndrome

By Benzinga Newsdesk

February 7, 9:25 AM

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced

RYTM

5 minute read

Denali Therapeutics Announces New Data And Expansion Of Its Blood-Brain Barrier-Crossing Enzyme Replacement Therapy Programs At WORLDSymposium

By Benzinga Newsdesk

February 7, 9:22 AM

New data show additional improvement and stabilization in clinical outcomes in MPS II with 104 weeks of tividenofusp alfa (DNL310) treatment in the open-label, single-arm Phase 1/2 study; sustained normalization of CSF

DNLI

1 minute read

Daxor Corporation Closes Q4 2023 With Growth In New Sales To Hospital Systems And Increased Utilization Of Its BVA-100 Blood Volume Diagnostic Across The U.S. At Existing Accounts

By Benzinga Newsdesk

February 7, 9:06 AM

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood

DXR

3 minute read

Theriva Biologics Announces Positive Recommendation From The Independent Data Monitoring Committee Of VIRAGE, The Phase 2b Clinical Trial Of VCN-01 In Combination With Chemotherapy For Metastatic Pancreatic Ductal Adenocarcinoma

By Benzinga Newsdesk

February 7, 9:02 AM

Theriva™ Biologics (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that the Independent Data

TOVX

2 minute read

Amazon Implements Major Job Cuts In One Medical And Pharmacy Units To Save $100M

By Benzinga Neuro

February 6, 11:46 PM

Amazon has announced that it will lay off hundreds of employees at its One Medical and Pharmacy units as part of a major cost-cutting initiative.

AMZN

1 minute read

JP Morgan’s Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point

By Vandana Singh

February 6, 3:37 PM

BeiGene's JP Morgan coverage highlights upside in valuation post-pullback. Brukinsa's success and Tevimbra's potential add to the optimism. Overweight rating, $185 price target.

BGNE

2 minute read

UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst

By Vandana Singh

February 6, 3:19 PM

UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

ABBV